Morgan Stanley analyst Adam Jonas maintains QuantumScape (NYSE:QS) with a Equal-Weight and lowers the price target from $40 to $30.
Daiwa Capital Downgrades Amgen to Neutral, Announces $220 Price Target
Daiwa Capital analyst Narumi Nakagiri downgrades Amgen (NASDAQ:AMGN) from Outperform to Neutral and announces $220 price target.